Certara Set to Join Russell 1000® Index
Certara, a leader in biosimulation, is set to join the Russell 1000® Index effective March 22, 2021. This inclusion is based on its strong financial performance and reflects the growing adoption of its biosimulation platform. The Russell 1000 Index tracks the 1,000 largest companies in the U.S., and membership can enhance visibility among institutional investors, with approximately $9 trillion in assets benchmarked to these indexes. Certara aims to leverage this milestone to increase stock awareness within the investment community.
- Inclusion in the Russell 1000 Index boosts visibility in the investment community.
- Reflects strong financial performance and customer adoption of biosimulation technologies.
- None.
Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it is set to join the Russell 1000® Index, effective after the U.S. market open on March 22, 2021, according to a preliminary list of quarterly IPO additions posted February 26, 2021.
The Russell 1000® Index measures the performance of the 1,000 largest companies in the Russell 3000® Index based on total market capitalization. Membership in the Russell 1000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000® Index.
“Certara’s anticipated inclusion in the Russell 1000® validates our strong financial performance as our customers continue to grow their adoption of biosimulation and our end-to-end platform,” said William F. Feehery, chief executive officer of Certara. “We are proud to have achieved this major milestone that will increase awareness of our stock in the investment community.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately
For more information on the Russell 1000® Index and the Russell U.S. Indexes, go to the FTSE Russell website.
About Certara:
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.
About FTSE Russell:
FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles. FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005627/en/
FAQ
When will Certara join the Russell 1000 Index?
What does inclusion in the Russell 1000 Index mean for Certara?
What is the Russell 1000 Index?
How much assets are benchmarked to Russell's U.S. indexes?